Park JW - Search Results

1

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC. Park JW, et al. Clin Cancer Res. 2002 Apr;8(4):1172-81. Clin Cancer Res. 2002. PMID: 11948130

2

Development of anti-p185HER2 immunoliposomes for cancer therapy.

Park JW, Hong K, Carter P, Asgari H, Guo LY, Keller GA, Wirth C, Shalaby R, Kotts C, Wood WI, et al. Park JW, et al. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1327-31. doi: 10.1073/pnas.92.5.1327. Proc Natl Acad Sci U S A. 1995. PMID: 7877976 Free PMC article.

3

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D. Kirpotin D, et al. Among authors: park jw. Biochemistry. 1997 Jan 7;36(1):66-75. doi: 10.1021/bi962148u. Biochemistry. 1997. PMID: 8993319

4

ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.

Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC. Chang CH, et al. Among authors: park jw. Oncogene. 1997 Apr 3;14(13):1617-22. doi: 10.1038/sj.onc.1200978. Oncogene. 1997. PMID: 9129154

5

Immunoliposomes for cancer treatment.

Park JW, Hong K, Kirpotin DB, Papahadjopoulos D, Benz CC. Park JW, et al. Adv Pharmacol. 1997;40:399-435. doi: 10.1016/s1054-3589(08)60146-5. Adv Pharmacol. 1997. PMID: 9217932 Review. No abstract available.

6

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

Park JW, Hong K, Kirpotin DB, Meyer O, Papahadjopoulos D, Benz CC. Park JW, et al. Cancer Lett. 1997 Oct 14;118(2):153-60. doi: 10.1016/s0304-3835(97)00326-1. Cancer Lett. 1997. PMID: 9459205

7

Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.

Meyer O, Kirpotin D, Hong K, Sternberg B, Park JW, Woodle MC, Papahadjopoulos D. Meyer O, et al. Among authors: park jw. J Biol Chem. 1998 Jun 19;273(25):15621-7. doi: 10.1074/jbc.273.25.15621. J Biol Chem. 1998. PMID: 9624154 Free article.

8

Anti-HER2 immunoliposomes for targeted drug delivery.

Hong K, Kirpotin DB, Park JW, Shao Y, Shalaby R, Colbern G, Benz CC, Papahadjopoulos D. Hong K, et al. Among authors: park jw. Ann N Y Acad Sci. 1999;886:293-6. doi: 10.1111/j.1749-6632.1999.tb09440.x. Ann N Y Acad Sci. 1999. PMID: 10667243 Review. No abstract available.

9

Liposome targeting to tumors using vitamin and growth factor receptors.

Drummond DC, Hong K, Park JW, Benz CC, Kirpotin DB. Drummond DC, et al. Among authors: park jw. Vitam Horm. 2000;60:285-332. doi: 10.1016/s0083-6729(00)60022-5. Vitam Horm. 2000. PMID: 11037627 Review.

10

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC. Park JW, et al. J Control Release. 2001 Jul 6;74(1-3):95-113. doi: 10.1016/s0168-3659(01)00315-7. J Control Release. 2001. PMID: 11489487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,110 results

Search Page

Filters